Skip to content
Noroxi
CVE-2025-4547· NVD / CVE Program· CNA VulDB

SourceCodester Web-based Pharmacy Product Management System Add User Page cross site scripting

Noroxi assessment

Priority: Monitor (action score 19/100)

  • The sources we track (CISA KEV, Exploit-DB, Metasploit, Nuclei, GitHub) show no public exploit code or exploitation in the wild.
  • Probability of exploitation in the next 30 days: 0.38% (FIRST EPSS).
  • Anyone who can reach it over the internet can trigger it. Administrator privileges are required. No special conditions are required; it is repeatable.
  • According to the record, no fixed version is available yet.

Low priority for now. Update when a fix is released; follow the vendor's advisory.

Generated automatically from the record's data: CVSS (NVD and CNA), CISA KEV and SSVC, FIRST EPSS, exploit sources, fixed versions. How we calculate it

Primary sources: NVD · CVE.org · FIRST EPSS

A vulnerability was found in SourceCodester Web-based Pharmacy Product Management System 1.0. It has been rated as problematic. Affected by this issue is some unknown functionality of the component Add User Page. The manipulation leads to cross site scripting. The attack may be launched remotely. The exploit has been disclosed to the public and may be used. Multiple parameters might be affected.

MediumCVSS 4.8 · v4.0—No exploit No fix recorded
Published
May 11, 2025
Updated
Jun 17, 2026
EPSS
0.3% · 31th percentile

Report tools

JSON

Action score

19

Monitor

Low priority for now.

CVSS
19 / 40 · 4.8 / 10
CISA KEV
0 / 30 · Not listed
EPSS
0 / 30 · 0.3%

CISA SSVC decision

Exploitation
proof of concept
Automatable
no
Technical impact
partial

Vulnrichment: CISA's decision-tree inputs.

CNA vs NVD score

NVD
—
CNA · VulDB
4.8
NVD has not scored this yet; the score shown is the CNA’s.

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N

The score given by the assigning authority versus NVD’s independent score. A gap means the severity is contested.

Get told when this record changes

  • Not in KEV: no record of exploitation in the wild
  • No public exploit code on record
  • No fixed version yet

If any of these changes, we'll tell you in the daily email digest.

Follow CVE-2025-4547

When you'll hear from us

  • when it enters CISA KEV
  • when exploit code appears or is weaponized
  • when the record is updated (including a fixed version)
  • when EPSS rises 20 points in a week

One daily email digest (06:00 UTC); connect a webhook for KEV listings and weaponized exploits instantly.

Your free account also gets you

Running WordPress? Scan your site free with WP Lens

  • Stack alerts: add the products and versions you run, get the new CVEs that affect them
  • Uptime monitoring: 1 site, instant email when it goes down
  • Add your domain: subdomains and takeover risk scanned every week (1 domain)
  • 10 scans an hour on the security tools (3 a day without an account), an API key and MCP
  • All your scans in one panel: findings, what changed in the last scan, a report per domain or per client (PDF, share link)
All free tools

Sign up with email · Have an account? Sign in

Free account, no card. Unfollow any time.

Don't want an account? Get "Exploited this week" by email every MondayDon't want an account? RSS feed for senior-walter records

Running WordPress? Scan your site free with WP Lens

Is your version affected? Check it

Noroxi analysis

What does it mean in your environment?

The assessment above is generated automatically from the record's data; it doesn't know your environment. Our team verifies on your systems whether this vulnerability is actually exploitable and which mitigation is enough.

We use this product, ask for help

Affected systems

Is your version affected?

Pick the product and type the version you run. It's compared with this record's version ranges in your browser; the version isn't sent anywhere.

VendorProduct
senior-walterweb-based pharmacy product management system

Limit the impact of XSS

This is a cross-site scripting (XSS) vulnerability. A well-configured Content-Security-Policy doesn't fix it, but greatly reduces its impact. Check your site's CSP and other security headers for free.

Check security headers

Affected versions

NVD version ranges (for catalog products). Add the product to your stack with a version and matching uses these.

  • senior-walter web-based pharmacy product management system1.0

Versions reported by the vendor

Affected version ranges reported by the assigning authority (VulDB). Independent of NVD's CPE analysis and usually ahead of it.

  • SourceCodester Web-based Pharmacy Product Management System

    • 1.0affected

Same product

senior-walter: all records

Other highest-scoring records for the same primary product.

  • CVE-2025-63712Cross-Site Request Forgery (CSRF) in SourceCodester Product Expiry Management System.
    35Monitor
  • CVE-2025-45997Sourcecodester Web-based Pharmacy Product Management System v.1.0 has a file upload vulnerability.
    34Monitor
  • CVE-2025-56274SourceCodester Web-based Pharmacy Product Management System 1.0 is vulnerable to Incorrect Access Control, which allows low-privileged users
    32Monitor

Published before and after this one in the same product

  • ← EarlierCVE-2025-3826Apr 20, 2025 · SourceCodester Web-based Pharmacy Product Management System add-supplier.php cross site scripting
    19Monitor
  • ← EarlierCVE-2025-45751May 5, 2025 · SourceCodester Web Based Pharmacy Product Management System 1.0 is vulnerable to Cross Site Scripting (XSS) in add-admin.php via the Fullnam
    24Monitor
  • Later →CVE-2025-56018Sep 30, 2025 · SourceCodester Web-based Pharmacy Product Management System V1.0 is vulnerable to Cross Site Scripting (XSS) in Category Management via the
    24Monitor

Remediation

Which version to upgrade to

Fix versions compiled from the vendor, package registries and Microsoft. Verify the vendor's note before upgrading.

No fix version is recorded for this entry. Check the references for vendor advisories.

Exploit status

No known public exploit

No public exploit has been observed yet. That doesn't mean you're safe, only that the bar is a little higher.

Research context

For pentesters and researchers: attack profile, score disagreement, timeline, patch commits, credits, variant and chain candidates, bug bounty scope. All derived from existing data; no exploit code.

Timeline

From publication to today: proof of concept, Metasploit module, CISA KEV and fix record. Dates are as reported by the sources.

No dated events beyond publication.

EPSS, last 120 days

FIRST EPSS daily score; only changes of 0.01 or more are recorded (step chart).

Patch and commit links

Commit, PR and diff links among the references. A starting point for patch-diffing and variant hunting; fixes, not exploits.

No commit or PR link among the references.

Credits

All researchers

Finders, reporters and analysts named in the CNA record. Click a name for that researcher’s other records.

Variant candidates

Same product, same weakness class, within 18 months. If the patch missed the root cause, the sibling bug is here.

  • CVE-2025-457516 days apartSourceCodester Web Based Pharmacy Product Management System 1.0 is vulnerable to Cross Site Scripting (XSS) in add-admin.php via the Fullnam
    24Monitor
  • CVE-2025-56018142 days apartSourceCodester Web-based Pharmacy Product Management System V1.0 is vulnerable to Cross Site Scripting (XSS) in Category Management via the
    24Monitor
  • CVE-2025-65215205 days apartSourcecodester Web-based Pharmacy Product Management System v1.0 is vulnerable to Cross Site Scripting (XSS) in /product_expiry/add-supplier
    24Monitor
  • CVE-2025-382421 days apartSourceCodester Web-based Pharmacy Product Management System add-product.php cross site scripting
    19Monitor
  • CVE-2025-382521 days apartSourceCodester Web-based Pharmacy Product Management System add-category.php cross site scripting
    19Monitor
  • CVE-2025-382621 days apartSourceCodester Web-based Pharmacy Product Management System add-supplier.php cross site scripting
    19Monitor

Chain candidates

An authentication bypass and a privilege-requiring bug in the same product, published close together: combined they may become an unauthenticated path.

—

Bug bounty scope

No known public program.

Source: bounty-targets-data (public HackerOne, Bugcrowd, Intigriti, YesWeHack listings).

Technical details

Attack conditions

  • Anyone who can reach it over the internet can trigger it.
  • Administrator privileges are required.
  • No special conditions are required; it is repeatable.

If successful

Confidentiality
Integrity
Availability
Attack vector
Network
Attack complexity
Low
Privileges required
High
User interaction
P
Scope
X

Weakness class (CWE)

CWE-79 · Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')

CVSS vector

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

nvd-secondary

Root cause

User content is inserted into the page as HTML. The browser interprets the content as code rather than data.

The bug in code

The whole CWE-79 class

A representative example of this vulnerability class. Not the vendor's source code; it shows the faulty pattern and its fix.

Vulnerable

ts
commentEl.innerHTML = comment.body;

Fixed

ts
commentEl.textContent = comment.body;

Attack context

MITRE CAPEC attack patterns and ATT&CK techniques for this weakness class (CWE). A starting point for detection rules and threat hunting.

ATT&CK techniques

—

Change log

No changes recorded on tracked fields yet. Score, KEV, exploit maturity and fix status changes appear here.

References

Show all references (3 more)

Vendor advisories and official records. Exploit/PoC links are deliberately left out.

All records